245 related articles for article (PubMed ID: 24219039)
1. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target.
Pincus T; Castrejón I
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S33-40. PubMed ID: 24219039
[TBL] [Abstract][Full Text] [Related]
2. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
Castrejón I; Gibson KA; Pincus T
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
[TBL] [Abstract][Full Text] [Related]
4. Update on methotrexate as the anchor drug for rheumatoid arthritis.
Pincus T; Gibson KA; Castrejón I
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S9-19. PubMed ID: 24219036
[TBL] [Abstract][Full Text] [Related]
5. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
8. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
9. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
Trials; 2015 Apr; 16():178. PubMed ID: 25896862
[TBL] [Abstract][Full Text] [Related]
10. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
[TBL] [Abstract][Full Text] [Related]
11. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
Graudal N; Jürgens G
Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
[TBL] [Abstract][Full Text] [Related]
12. Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.
Kremer J; Li ZG; Hall S; Fleischmann R; Genovese M; Martin-Mola E; Isaacs JD; Gruben D; Wallenstein G; Krishnaswami S; Zwillich SH; Koncz T; Riese R; Bradley J
Ann Intern Med; 2013 Aug; 159(4):253-61. PubMed ID: 24026258
[TBL] [Abstract][Full Text] [Related]
13. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
Levesque MC
BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
Bijlsma JW; Jacobs JW
Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
[TBL] [Abstract][Full Text] [Related]
15. Drug management of early rheumatoid arthritis - 2008.
Sokka T; Mäkinen H
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
[TBL] [Abstract][Full Text] [Related]
16. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
Feely MG; O'Dell JR
Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
Kobayashi S; Kanai Y
Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
[TBL] [Abstract][Full Text] [Related]
18. Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study.
Urata Y; Uesato R; Tanaka D; Nakamura Y; Motomura S
Ann Rheum Dis; 2012 Apr; 71(4):534-40. PubMed ID: 22021897
[TBL] [Abstract][Full Text] [Related]
19. The BeSt story: on strategy trials in rheumatoid arthritis.
Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
[TBL] [Abstract][Full Text] [Related]
20. Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis.
Jacobs JW
Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv3-8. PubMed ID: 22513146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
